Stories about Diabetes
- more
Roche teams up with Diabeloop to advance the management of insulin pump therapy
moreGrünenthal agrees to acquire European rights to CRESTOR [TM] (rosuvastatin) from AstraZeneca
moreFORA® 6 Blood Glucose Monitors Help Diabetic Patients Monitor COVID-19 Risks
moreFollow your gut: How farms protect from childhood asthma
moreAscensia Diabetes Care; PHC Holdings Corporation
PHC Holdings Corporation and Ascensia Diabetes Care Announce Financing Agreement and Exclusive Global Commercial Agreement With Senseonics
moreGrünenthal and Averitas Pharma Announce U.S. FDA Approval of QUTENZA® for the Treatment of Neuropathic Pain Associated with Diabetic Peripheral Neuropathy of the Feet
moreTechnische Universität München
Gut bacteria improve type 2 diabetes risk prediction
moreSwitching to Ozempic® from another GLP-1 RA significantly reduced blood sugar and weight in people with type 2 diabetes in routine clinical practice
moreInternational Atherosclerosis Society
International Atherosclerosis Society Issues Call to Action to Improve Lipid Management Based on Survey Results to Address Patients' Residual Risk
moreGalderma Global Research Reveals Struggles of People With Rosacea and Psoriasis of the Face Experiencing a Lack of Control and Impact on Mental Wellbeing
moreBeta cells from stem cells: Potential for cell replacement therapy
moreSaxenda® Demonstrated Improvements in BMI and Body Weight in Adolescents With Obesity
morePress release: STADA takes clear lead in Russian consumer healthcare sector
One documentmoreGerresheimer sets foundation for profitable growth in 2019
One documentmoreTechnische Universität München
Gene network helps to turn white fat into beneficial calorie burning fat
moreAveritas Pharma Announces FDA Acceptance of sNDA Filing for QUTENZA® (capsaicin) 8% Patch for the Treatment of Neuropathic Pain Associated with Diabetic Peripheral Neuropathy
moreForaCare Suisse AG Launches "Lab in the Pocket" Technology
moreNew Focus in Project Portfolio of Gerresheimer Subsidiary Sensile Medical
moreNew focus in project portfolio of Gerresheimer subsidiary Sensile Medical
moreOzempic® Offers Superior Reductions in HbA1c and Body Weight Compared to Both Victoza® and Canagliflozin in People With Type 2 Diabetes
morePrimary Care Diabetes Europe (PCDE)
Primary Care Diabetes Europe Issues Call to Action Against Clinical Inertia in the Treatment of Type-2 Diabetes
moreInternational Diabetes Federation (IDF) Global Survey Reveals 2 in 3 People With Type 2 Diabetes Have Cardiovascular Disease Risk Factors and/or Have Experienced a Cardiovascular Event
more
1